Mossi
James Mossi, Trevano (como) IT
Patent application number | Description | Published |
---|---|---|
20100296905 | LOADING/UNLOADING SYSTEM SERVING A SHEET CUTTING CENTRE, FEEDING TRAY THEREFOR AND RELATIVE HANDLING METHOD - A system for loading/unloading sheets is disclosed, some of which also being of metal, and handling method thereof, serving a laser cutting centre. The system includes a pair of rails ( | 11-25-2010 |
Waldo Mossi, Mendrisio CH
Patent application number | Description | Published |
---|---|---|
20100105724 | CRYSTALLINE AND AMORPHOUS FORMS OF PALONOSETRON HYDROCHLORIDE - Amorphous and polymorphic of palonosetron hydrochloride are disclosed that can be characterized by X-ray powder diffraction patterns, thermal properties, purity and methods of manufacture. These forms of palonosetron hydrochloride can be produced from solution or by solid state interconversions. The forms can be used in pharmaceutical formulations: particularly preferred uses of these formulations are in prevention and treatment of nausea and emesis arising from chemotherapy or postoperative side effects. The forms can optionally be used as mixtures of the crystalline and/or amorphous forms. | 04-29-2010 |
20120253046 | PALONOSETRON METABOLITES - Provided are metabolites of palonosetron that can be used in treating animals, particularly humans, of the formula (I): or a pharmaceutically acceptable salt or prodrug thereof; wherein R | 10-04-2012 |
Waldo Mossi, Mendrisio (ti) CH
Patent application number | Description | Published |
---|---|---|
20140171646 | AMORPHOUS FORMS OF PALONOSETRON HYDROCHLORIDE - Amorphous and polymorphic of palonosetron hydrochloride are disclosed that can be characterized by X-ray powder diffraction patterns, thermal properties, purity and methods of manufacture. These forms of palonosetron hydrochloride can be produced from solution or by solid state interconversions. The forms can be used in pharmaceutical formulations: particularly preferred uses of these formulations are in prevention and treatment of nausea and emesis arising from chemotherapy or postoperative side effects. The forms can optionally be used as mixtures of the crystalline and/or amorphous forms. | 06-19-2014 |